Search results for “Anti-Epidermal Growth Factor Receptor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 185 patents, we discovered top 41 key players by total patent application. Merrimack Pharmaceuticals, Inc., Halozyme, Inc., AbbVie, Inc. are dominant in this area. They take 38.38% of the total patent filing.
Merrimack Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 31
Halozyme, Inc.
California, United States
Patent: 26
AbbVie, Inc.
Illinois, United States
Patent: 14
Centre of Molecular Immunology
Cuba
Patent: 11
Merck Patent GmbH
Hessen, Germany
Patent: 11
Amgen, Inc.
California, United States
Patent: 9
Shanghai Henlius Biotech, Inc.
Shanghai Shi, China
Patent: 9
UAB Research Foundation
Alabama, United States
Patent: 8
Wellstat Biologics Corp.
United States
Patent: 5
Institut National de la Santé et de la Recherche Médicale
France
Patent: 5
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 24 patents applied in the last 5 years. We discover 21 most active companies in this area. The fast-growing Institut National de la Santé et de la Recherche Médicale, United States of America, Shanghai Henlius Biotech, Inc. take 37.50% of patent filing during this period.
Institut National de la Santé et de la Recherche Médicale
France
Patent: 4
United States of America
United States
Patent: 3
Shanghai Henlius Biotech, Inc.
Shanghai Shi, China
Patent: 2
Department of Health & Human Services
Australia
Patent: 2
Genentech, Inc.
California, United States
Patent: 2
AbbVie, Inc.
Illinois, United States
Patent: 2
Centre National De La Recherche Scientif
France
Patent: 2
Université de Montpellier I
France
Patent: 2
Yeda Research & Development Co. Ltd.
Israel
Patent: 2
Institut régional du Cancer de Montpellier
France
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 24 patents in last 5 years, we discover 6 new entrants. Université de Montpellier I, Institut régional du Cancer de Montpellier, University of Nice Sophia Antipolis are the most active new entrants in this area.
Université de Montpellier I
France
Patent: 2
Institut régional du Cancer de Montpellier
France
Patent: 2
University of Nice Sophia Antipolis
France
Patent: 1
Shunho Cell Biotech Tianjin Co., Ltd.
Tianjin Shi, China
Patent: 1
Jining University
Shandong Sheng, China
Patent: 1
Shanghai Miracogen Inc.
Shanghai Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 41 patents, we discovered top 8 universities and scientific research institutions by total patent application. Albert Einstein College of Medicine, Inc., Université d'Aix-Marseille, Medizinische Universität Graz are dominant in this area. They take 65.85% of the total patent filing.
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 15
Université d'Aix-Marseille
France
Patent: 4
Medizinische Universität Graz
Steiermark, Austria
Patent: 3
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 2
Rutgers State University of New Jersey
New Mexico, United States
Patent: 1
Central South University
Hunan Sheng, China
Patent: 1
University of Nice Sophia Antipolis
France
Patent: 1
Tunghai University
Taiwan Province, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: